Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | |
|---|---|---|---|---|---|---|
| Total revenue | 241.34%956.74K | -30.68%280.29K | -5.93%404.35K | 18.37%429.85K | 35.73%363.12K | 267.54K |
| Operating revenue | 241.34%956.74K | -30.68%280.29K | -5.93%404.35K | 18.37%429.85K | 35.73%363.12K | --267.54K |
| Cost of revenue | ||||||
| Gross profit | 241.34%956.74K | -30.68%280.29K | -5.93%404.35K | 18.37%429.85K | 35.73%363.12K | 267.54K |
| Operating expense | 10.52%3.74M | -24.42%3.39M | -13.36%4.48M | -2.02%5.17M | 84.04%5.28M | 2.87M |
| Selling and administrative expenses | 5.33%2.56M | -36.74%2.43M | -2.61%3.84M | 1.13%3.94M | 80.01%3.9M | --2.16M |
| -Selling and marketing expense | -82.07%7.62K | -79.36%42.51K | -60.87%206.01K | -49.67%526.51K | 360.06%1.05M | --227.4K |
| -General and administrative expense | 6.89%2.55M | -34.33%2.39M | 6.38%3.63M | 19.78%3.41M | 47.14%2.85M | --1.94M |
| Depreciation amortization depletion | 27.26%94.38K | -7.87%74.16K | -48.89%80.49K | 41.58%157.47K | 74.64%111.22K | --63.69K |
| -Depreciation and amortization | 27.26%94.38K | -7.87%74.16K | -48.89%80.49K | 41.58%157.47K | 74.64%111.22K | --63.69K |
| Other operating expenses | 23.31%1.09M | 57.02%886.2K | -47.53%564.4K | -15.47%1.08M | 98.56%1.27M | --640.86K |
| Operating profit | 10.30%-2.79M | 23.80%-3.11M | 14.03%-4.08M | 3.52%-4.74M | -89.00%-4.92M | -2.6M |
| Net non-operating interest income (expenses) | 6.62%-76.38K | -369.07%-81.8K | -459.63%-17.44K | 77.71%-3.12K | 19.09%-13.98K | -17.28K |
| Non-operating interest income | -13.73%7.85K | 15.93%9.1K | 1,257.27%7.85K | 307.04%578 | 21.37%142 | --117 |
| Non-operating interest expense | -16.42%70.11K | 265.87%83.89K | 1,011.93%22.93K | -75.67%2.06K | 657.46%8.48K | --1.12K |
| Total other finance cost | 101.51%14.12K | 197.45%7.01K | 44.30%2.36K | -71.09%1.63K | -65.31%5.65K | --16.28K |
| Other net income (expenses) | -33.39%619.53K | -15.25%930.07K | 34.85%1.1M | 44.20%813.8K | 773.64%564.37K | 64.6K |
| Other non-operating income (expenses) | -33.39%619.53K | -15.25%930.07K | 34.85%1.1M | 44.20%813.8K | 773.64%564.37K | --64.6K |
| Income before tax | 0.67%-2.24M | 24.64%-2.26M | 23.77%-3M | 9.81%-3.93M | -70.74%-4.36M | -2.55M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Earnings from equity interest net of tax | ||||||
| Net income | 0.67%-2.24M | 24.64%-2.26M | 23.77%-3M | 9.81%-3.93M | -70.74%-4.36M | -2.55M |
| Net income continuous operations | 0.67%-2.24M | 24.64%-2.26M | 23.77%-3M | 9.81%-3.93M | -70.74%-4.36M | ---2.55M |
| Noncontrolling interests | ||||||
| Net income attributable to the company | 0.67%-2.24M | 24.64%-2.26M | 23.77%-3M | 9.81%-3.93M | -70.74%-4.36M | -2.55M |
| Preferred stock dividends | ||||||
| Other under preferred stock dividend | ||||||
| Net income attributable to common stockholders | 0.67%-2.24M | 24.64%-2.26M | 23.77%-3M | 9.81%-3.93M | -70.74%-4.36M | -2.55M |
| Diluted earnings per share | 51.00%-0.0049 | 44.44%-0.01 | 47.25%-0.018 | 57.92%-0.0341 | -55.09%-0.0811 | -0.0523 |
| Basic earnings per share | 51.00%-0.0049 | 44.44%-0.01 | 47.25%-0.018 | 57.92%-0.0341 | -55.09%-0.0811 | -0.0523 |
| Dividend per share | ||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |